362 related articles for article (PubMed ID: 8107229)
1. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the conserved cysteine residues in the simian immunodeficiency virus matrix protein.
González SA; Affranchino JL
Virology; 1995 Jul; 210(2):501-7. PubMed ID: 7618287
[TBL] [Abstract][Full Text] [Related]
4. Efficient HIV-1 replication can occur in the absence of the viral matrix protein.
Reil H; Bukovsky AA; Gelderblom HR; Göttlinger HG
EMBO J; 1998 May; 17(9):2699-708. PubMed ID: 9564051
[TBL] [Abstract][Full Text] [Related]
5. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
6. Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.
Lee YM; Tang XB; Cimakasky LM; Hildreth JE; Yu XF
J Virol; 1997 Feb; 71(2):1443-52. PubMed ID: 8995670
[TBL] [Abstract][Full Text] [Related]
7. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.
Yu X; Yuan X; Matsuda Z; Lee TH; Essex M
J Virol; 1992 Aug; 66(8):4966-71. PubMed ID: 1629961
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.
Yu X; Yuan X; McLane MF; Lee TH; Essex M
J Virol; 1993 Jan; 67(1):213-21. PubMed ID: 8416370
[TBL] [Abstract][Full Text] [Related]
9. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
10. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.
González SA; Burny A; Affranchino JL
J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267
[TBL] [Abstract][Full Text] [Related]
11. Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.
Manrique JM; Celma CC; Hunter E; Affranchino JL; González SA
J Virol; 2003 Oct; 77(20):10881-8. PubMed ID: 14512538
[TBL] [Abstract][Full Text] [Related]
12. Dominant Negative MA-CA Fusion Protein Is Incorporated into HIV-1 Cores and Inhibits Nuclear Entry of Viral Preintegration Complexes.
Anderson-Daniels J; Singh PK; Sowd GA; Li W; Engelman AN; Aiken C
J Virol; 2019 Nov; 93(21):. PubMed ID: 31413124
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
14. Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation.
West JT; Weldon SK; Wyss S; Lin X; Yu Q; Thali M; Hunter E
J Virol; 2002 Apr; 76(7):3338-49. PubMed ID: 11884559
[TBL] [Abstract][Full Text] [Related]
15. Caprine arthritis-encephalitis virus envelope surface glycoprotein regions interacting with the transmembrane glycoprotein: structural and functional parallels with human immunodeficiency virus type 1 gp120.
Hötzel I; Cheevers WP
J Virol; 2003 Nov; 77(21):11578-87. PubMed ID: 14557643
[TBL] [Abstract][Full Text] [Related]
16. Analysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions.
Alfadhli A; Staubus AO; Tedbury PR; Novikova M; Freed EO; Barklis E
J Virol; 2019 Nov; 93(21):. PubMed ID: 31375589
[TBL] [Abstract][Full Text] [Related]
17. Direct interaction between the envelope and matrix proteins of HIV-1.
Cosson P
EMBO J; 1996 Nov; 15(21):5783-8. PubMed ID: 8918455
[TBL] [Abstract][Full Text] [Related]
18. Characterization of human immunodeficiency virus type 1 matrix revertants: effects on virus assembly, Gag processing, and Env incorporation into virions.
Ono A; Huang M; Freed EO
J Virol; 1997 Jun; 71(6):4409-18. PubMed ID: 9151831
[TBL] [Abstract][Full Text] [Related]
19. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
[TBL] [Abstract][Full Text] [Related]
20. Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.
Poon DT; Li G; Aldovini A
J Virol; 1998 Mar; 72(3):1983-93. PubMed ID: 9499052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
